Tulip Biosciences

Year 2025
Area Healthcare and Medical

Turning Mucus into Medicine

Tulip Biosciences harnesses the body’s first line of defense—mucus—to restore health where natural barriers fail. Using insights from mucus biology, we develop safe, antibiotic-sparing biomaterials that address a range of conditions, beginning with women’s health, where unmet need is high and innovation has been long overdue.

Interview with Kelsey Wheeler, postdoc in Katharina Ribbeck’s lab, and now scientific founder for Tulip.
Kelsey Wheeler talks about Tulip, a company developing mucin glycan-derived therapeutics for infectious vaginitis at IdeaStream 2025.

Mucin glycan-derived therapeutics for infectious vaginitis

A mucin-inspired technology that would deliver infection-fighting sugars to treat and prevent infectious vaginitis, and ease discomfort.